Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT07148635
Eligibility Criteria:
Inclusion Criteria:
* Both male and female gender will be included (Fernández-Carnero, 2021).
* Clinically diagnosed of chronic low back pain persisting for at least three months (Tüzün et al., 2017)
* Identifiable active myofascial trigger points in the lower back muscles, confirmed through palpation or another standardized method (Donohoe, 2016).
* Moderate to severe pain intensity, measured by a visual analog scale (VAS) (Tüzün et al., 2017)
* Sufficient cognitive and physical ability to engage in assessments and interventions (Tüzün et al., 2017)
Exclusion Criteria:
* Known hypersensitivity to needles, history of severe bleeding disorders, or any condition that contraindicates dry needling (Tüzün et al., 2017)
* Use of other physical therapy interventions or dry needling treatments in the last three months for low back pain (Fernández-Carnero, 2021).
* Presence of specific spinal conditions (e.g., disc herniation, spinal stenosis, fractures, or recent spinal surgeries) (Tüzün et al., 2017)
* History of neurological conditions affecting movement, sensation, or pain perception, such as multiple sclerosis or peripheral neuropathy (Donohoe, 2016)
* Pregnant women will be excluded due to potential risks associated with the interventions (Tüzün et al., 2017)
* Unstable psychiatric conditions or active substance abuse that could interfere with participation or adherence to study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
25 Years
Study:
NCT07148635
Study Brief:
Protocol Section:
NCT07148635